Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
SNDX.OQ - Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc at TD Cowen Oncology Innovation Summit (Virtual)
May 27, 2026 / 05:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome once again to TD Cowen's seventh annual Oncology Innovation Summit. I'm Phil Nadeau, one of the biotech analysts here at Cowen. It's my pleasure to moderate a fireside chat with Syndex. We have with us today Michael Metzger, the CEO and Nick Botwood, the head of R&D and CMO. Guys, I'll hand it to you for a brief introduction. Could you give us a state of the company overview, biggest strengths, biggest challenges and what does Syndex need to do to create shareholder value over the next year?
--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------------------------
